10-Mar-2008 - MedImmune is taking advantage of a new US recommendation on the immunisation of school children to almost triple production of its intranasal influenza vaccine, FluMist, for the coming 'flu season.
Link to Article
In-Pharmatechnologist.com
|
|
||||||||
|
This Month
Month Archive
RSS Newsfeeds
Main Page RSS
|
ACIP recommendations are a seasonal bounty for FluMist
No comments found.
|
Search
Links
|
||||||